The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $45,429.60 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NUCALA 100 MG/ML AUTO-INJECTORML. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,678.70 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Nucala 100 mg/ml auto-injectors. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a comprehensive range of pharmaceutical items to fulfill the recurring...
The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,357.40, is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NUCALA 100 MG/ML auto-injectors. The contract, valued at $11,357.40, has a period of performance through May 23, 2024. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which allows the agency to place orders for a wide range of...
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NUCALA 100 mg/mL auto-injectors. This order is part of a larger indefinite-delivery contract (DLA Contract #4600082013) valued at up to $4,999,999 through 2025, which enables DLA to issue delivery orders for a broad range of pharmaceutical products to support military health facilities worldwide. DMS Pharmaceutical Group...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NUCALA 100 MG/ML auto-injectors. The potential value of this contract is $5,678.70, with a completion date of February 27, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to U.S. government...
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract worth $5,678.70 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of NUCALA 100 MG/ML auto-injectors. This contract has an ultimate completion date of April 11, 2024 and is not associated with any set-aside program. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the SPE2DB program, valued at up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,929.00, is to provide the NUCALA 100 MG/ML auto-injector to support the recurring medical supply needs of military health facilities. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NUCALA 100 MG/ML AUTO-INJECTOR. The delivery order, with a potential value of $1,892.90, has a performance period through December 27, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and medical...
The U.S. Defense Logistics Agency awarded a $7,571.60 firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the pharmaceutical product NUCALA 100 MG/ML AUTO-INJECTORML. This order was placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, which has a total potential value of up to $4,999,999 through 2025. The contract enables the DLA to issue delivery orders for a broad range of...